Eliciting the Monetary Value of a Quality-Adjusted Life Year in a Greek Outpatient Department in Times of Economic Austerity [0.03%]
希腊经济紧缩时期门诊部门的健康相关生命质量的货币价值的调研
A Mavrodi,V Aletras,A Spanou et al.
A Mavrodi et al.
Background and objective: Contingent valuation is widely used to determine individuals' willingness to pay (WTP) for a health gain. Our study aimed to elicit an empirical estimate of the monetary value of a quality-adjust...
Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values [0.03%]
统计嬗变：概念效度与生成健康状态功效值的映射问题
Jeff Round,Annie Hawton
Jeff Round
Mapping between non-preference- and preference-based health-related quality-of-life instruments has become a common technique for estimating health state utility values for use in economic evaluations. Despite the increased use of mapped he...
Utilization of Intergovernmental Funds to Implement Maternal and Child Health Plans of a Multi-Strategy Community Intervention in Haryana, North India: A Retrospective Assessment [0.03%]
印度哈里亚纳邦北部多策略社区干预项目中实施母子健康计划的际政府资金使用情况：回顾性评估
Madhu Gupta,Federica Angeli,Hans Bosma et al.
Madhu Gupta et al.
Introduction: A multi-strategy community intervention known as the National Rural Health Mission (NRHM) was implemented in India from 2005 to 2012 in an attempt to reduce maternal and child mortality. ...
Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR) [0.03%]
泛加拿大肿瘤药物评审(pCODR)中经济评估的方法学问题
Lisa Masucci,Jaclyn Beca,Mona Sabharwal et al.
Lisa Masucci et al.
Background: Public drug plans are faced with increasingly difficult funding decisions. In Canada, the pan-Canadian Oncology Drug Review (pCODR) makes funding recommendations to the provincial and territorial drug plans re...
Choosing Between Unicompartmental and Total Knee Replacement: What Can Economic Evaluations Tell Us? A Systematic Review [0.03%]
单髁膝关节置换术和全膝关节置换术的经济评估系统评价及 meta 分析
Edward Burn,Alexander D Liddle,Thomas W Hamilton et al.
Edward Burn et al.
Background and objective: Patients with anteromedial arthritis who require a knee replacement could receive either a unicompartmental knee replacement (UKR) or a total knee replacement (TKR). This review has been undertak...
Can Price Transparency Contribute to More Affordable Patient Access to Medicines? [0.03%]
价格透明能否助力患者更便捷地获得药品？
Sabine Vogler,Kenneth R Paterson
Sabine Vogler
Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib [0.03%]
日本慢性淋巴细胞性白血病患者的疾病经济负担及ibrutinib上市的预算影响分析
Jörg Mahlich,Shinichiro Okamoto,Akiko Tsubota
Jörg Mahlich
Background: Ibrutinib was introduced in Japan in 2016 as a new oral treatment option for patients with relapsed/refractory (RR) chronic lymphocytic leukemia (CLL). There is increasing interest from the Japanese government...
Cost-Effectiveness of Haemorrhoidal Artery Ligation versus Rubber Band Ligation for the Treatment of Grade II-III Haemorrhoids: Analysis Using Evidence from the HubBLe Trial [0.03%]
基于HubBLe试验证据的II至III期内痔患者橡皮圈套扎与硬化剂注射治疗的成本效益分析
Abualbishr Alshreef,Allan J Wailoo,Steven R Brown et al.
Abualbishr Alshreef et al.
Aim: Haemorrhoids are a common condition, with nearly 30,000 procedures carried out in England in 2014/15, and result in a significant quality-of-life burden to patients and a financial burden to the healthcare system. Th...
Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology [0.03%]
常见病与罕见病增量成本效果比差异——来自肿瘤学的一个案例分析
Kavisha Jayasundara,Murray Krahn,Muhammad Mamdani et al.
Kavisha Jayasundara et al.
Background: Incremental cost-effectiveness ratios (ICERs) are used to assess the value for money of new drugs. Many believe that ICERs for drugs that treat rare diseases are much higher than those of common drugs. Our obj...
Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the Implications [0.03%]
尼日利亚公共医疗保健机构治疗 uncomplicated 疟疾的费用评估及其影响
Charles C Ezenduka,Daniel Resende Falleiros,Brian B Godman
Charles C Ezenduka
Background: Accurate information on the facility costs of treatment is essential to enhance decision making and funding for malaria control. Objective: ...